ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 174 filers reported holding ACORDA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 2.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $193,000 | -6.3% | 67,129 | +333.2% | 0.01% | -22.2% |
| Q1 2019 | $206,000 | -80.9% | 15,495 | -77.7% | 0.01% | -57.1% |
| Q4 2018 | $1,081,000 | +398.2% | 69,415 | +816.0% | 0.02% | +162.5% |
| Q2 2018 | $217,000 | -40.1% | 7,578 | -55.1% | 0.01% | -11.1% |
| Q4 2017 | $362,000 | +39.2% | 16,886 | +36.2% | 0.01% | +12.5% |
| Q1 2017 | $260,000 | -38.2% | 12,400 | -44.6% | 0.01% | -27.3% |
| Q4 2016 | $421,000 | +22.0% | 22,400 | +65.4% | 0.01% | +57.1% |
| Q2 2016 | $345,000 | -47.0% | 13,546 | -45.0% | 0.01% | -58.8% |
| Q1 2016 | $651,000 | +37.6% | 24,615 | +73.3% | 0.02% | +13.3% |
| Q1 2015 | $473,000 | -4.6% | 14,200 | -16.5% | 0.02% | -37.5% |
| Q4 2013 | $496,000 | +88.6% | 17,000 | +120.8% | 0.02% | +118.2% |
| Q3 2013 | $263,000 | +7.8% | 7,700 | +4.1% | 0.01% | -38.9% |
| Q2 2013 | $244,000 | – | 7,400 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
| DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
| Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
| Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
| DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
| Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
| Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
| Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
| Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |